Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacob M Rowe

Showing results (261-270 of 275) with videos related to

Pageof 28
Sort By:
Cancer|June 18, 2016
Does FLT3 mutation impact survival after hematopoietic stem cell transplantation for acute myeloid leukemia? A Center for International Blood and Marrow Transplant Research (CIBMTR) analysisAbhinav Deol, Salyka Sengsayadeth, Kwang Woo Ahn, et al.
Blood|December 4, 2014
A genome-wide association study of susceptibility to acute lymphoblastic leukemia in adolescents and young adultsVirginia Perez-Andreu, Kathryn G Roberts, Heng Xu, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 1, 2019
Maintenance Tyrosine Kinase Inhibitors Following Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Myelogenous Leukemia: A Center for International Blood and Marrow Transplant Research StudyZachariah DeFilipp, Richard Ancheta, Ying Liu, et al.
The New England Journal of Medicine|July 24, 2024
Blinatumomab for MRD-Negative Acute Lymphoblastic Leukemia in AdultsMark R Litzow, Zhuoxin Sun, Ryan J Mattison, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 20, 2014
Allotransplantation for patients age ≥40 years with non-Hodgkin lymphoma: encouraging progression-free survivalBrian L McClune, Kwang Woo Ahn, Hai-Lin Wang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 4, 2011
Classifying cytogenetics in patients with acute myelogenous leukemia in complete remission undergoing allogeneic transplantation: a Center for International Blood and Marrow Transplant Research studyPhilippe Armand, Haesook T Kim, Mei-Jie Zhang, et al.
Blood Advances|September 22, 2021
Risk classification at diagnosis predicts post-HCT outcomes in intermediate-, adverse-risk, and KMT2A-rearranged AMLKamal Menghrajani, Alexandra Gomez-Arteaga, Rafael Madero-Marroquin, et al.
Cancer Discovery|June 9, 2021
Enhancer Hijacking Drives Oncogenic <i>BCL11B</i> Expression in Lineage-Ambiguous Stem Cell LeukemiaLindsey E Montefiori, Sonja Bendig, Zhaohui Gu, et al.
Nature Communications|November 9, 2016
Genomic analyses identify recurrent MEF2D fusions in acute lymphoblastic leukaemiaZhaohui Gu, Michelle Churchman, Kathryn Roberts, et al.
Nature Genetics|January 16, 2019
PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemiaZhaohui Gu, Michelle L Churchman, Kathryn G Roberts, et al.
Pageof 28

Showing results (261-270 of 275) with videos related to

Sort By:
Pageof 28
Cancer|June 18, 2016
Does FLT3 mutation impact survival after hematopoietic stem cell transplantation for acute myeloid leukemia? A Center for International Blood and Marrow Transplant Research (CIBMTR) analysisAbhinav Deol, Salyka Sengsayadeth, Kwang Woo Ahn, et al.
Blood|December 4, 2014
A genome-wide association study of susceptibility to acute lymphoblastic leukemia in adolescents and young adultsVirginia Perez-Andreu, Kathryn G Roberts, Heng Xu, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 1, 2019
Maintenance Tyrosine Kinase Inhibitors Following Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Myelogenous Leukemia: A Center for International Blood and Marrow Transplant Research StudyZachariah DeFilipp, Richard Ancheta, Ying Liu, et al.
The New England Journal of Medicine|July 24, 2024
Blinatumomab for MRD-Negative Acute Lymphoblastic Leukemia in AdultsMark R Litzow, Zhuoxin Sun, Ryan J Mattison, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 20, 2014
Allotransplantation for patients age ≥40 years with non-Hodgkin lymphoma: encouraging progression-free survivalBrian L McClune, Kwang Woo Ahn, Hai-Lin Wang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 4, 2011
Classifying cytogenetics in patients with acute myelogenous leukemia in complete remission undergoing allogeneic transplantation: a Center for International Blood and Marrow Transplant Research studyPhilippe Armand, Haesook T Kim, Mei-Jie Zhang, et al.
Blood Advances|September 22, 2021
Risk classification at diagnosis predicts post-HCT outcomes in intermediate-, adverse-risk, and KMT2A-rearranged AMLKamal Menghrajani, Alexandra Gomez-Arteaga, Rafael Madero-Marroquin, et al.
Cancer Discovery|June 9, 2021
Enhancer Hijacking Drives Oncogenic <i>BCL11B</i> Expression in Lineage-Ambiguous Stem Cell LeukemiaLindsey E Montefiori, Sonja Bendig, Zhaohui Gu, et al.
Nature Communications|November 9, 2016
Genomic analyses identify recurrent MEF2D fusions in acute lymphoblastic leukaemiaZhaohui Gu, Michelle Churchman, Kathryn Roberts, et al.
Nature Genetics|January 16, 2019
PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemiaZhaohui Gu, Michelle L Churchman, Kathryn G Roberts, et al.
Pageof 28